Bill
Bill > S1701
MA S1701
To eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
summary
Introduced
01/22/2019
01/22/2019
In Committee
01/22/2019
01/22/2019
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
191st General Court
Bill Summary
For legislation to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing. Revenue.
AI Summary
This bill aims to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing. Specifically, it proposes amending the definition of "net income" in Massachusetts' tax code to disallow deductions for the costs associated with advertising prescription drugs and devices directly to patients, including media advertising, coupons, outreach programs, and other forms of marketing directed at consumers rather than licensed prescribers. The bill seeks to remove this tax benefit in order to generate additional revenue.
Committee Categories
Budget and Finance
Sponsors (2)
Last Action
Accompanied a study order, see H5080 (on 11/02/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/191/S1701 |
| Bill | https://malegislature.gov/Bills/191/S1701.pdf |
Loading...